Skip to main content
INBIOGEN CO.,Ltd logo

INBIOGEN CO.,Ltd — Investor Relations & Filings

Ticker · 101140 ISIN · KR7101140002 KO Professional, scientific and technical activities
Open in API
Filings indexed 341 across all filing types
Latest filing 2025-01-22 Earnings Release
Country KR South Korea
Listing KO 101140

About INBIOGEN CO.,Ltd

https://www.inbiogen.com/

INBIOGEN is a life sciences company that provides Virtual Biotech Assistance to international biotechnology companies, pharmaceutical firms, and research organizations. The company specializes in harnessing data mining to deliver a range of services, including bioinformatics, custom data curation, database development, and the creation of operational platforms. Core bioinformatics offerings encompass data analysis, protein modeling, homology searches, phylogeny, and immunogenicity analysis. Additionally, INBIOGEN provides virtual research, marketing assistance, and web development services. The company focuses on creating customized, value-added solutions through a team of experienced scientists and bioinformatics professionals to help clients address challenges and utilize online resources effectively.

Recent filings

Filing Released Lang Actions
매출액또는손익구조30%(대규모법인은15%)이상변경
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (Inbiogen) announcing a significant change (30% or more) in revenue or profit structure. This is a standard disclosure requirement for listed companies in Korea to provide preliminary financial results before the final audit report is filed. Since it provides key financial highlights and reasons for the change, it fits the definition of an Earnings Release (ER). FY 2024
2025-01-22 Korean
[기재정정]사업보고서 (2022.12)
Audit Report / Information Classification · 97% confidence The document is a 'Financial Statement Audit Report' (감사보고서) for the company 'Inbiogen' (주식회사 인바이오젠). It includes the independent auditor's report, financial statements (balance sheet, income statement, etc.), and notes. Although it mentions a correction (정정) to a previously filed report, the document itself contains the full audited financial statements and the auditor's opinion, which classifies it as an Audit Report (AR) rather than a simple announcement or a full 10-K annual report (which typically includes management discussion and analysis, business descriptions, etc., beyond just the audit and financial statements). FY 2022
2025-01-10 Korean
[기재정정]사업보고서 (2023.12)
Annual Report Classification · 95% confidence The document is a formal 'Correction Report' (정정신고) for a previously filed 'Annual Report' (사업보고서). It details specific line-item corrections to financial statements, management discussion and analysis (MDA), and audit opinions. Since it is a correction to an existing annual report and contains substantive financial data updates, it is classified as an Annual Report (10-K) filing type, as it serves as an amendment to the primary annual financial disclosure. FY 2023
2025-01-10 Korean
[기재정정]감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) system regarding the submission of an audit report. It specifically details a correction (amendment) to a previously filed audit report, providing updated financial figures and audit opinions. While it contains financial data, it is a formal regulatory announcement of an audit report submission rather than the full annual report itself. Therefore, it falls under the category of Audit Report / Information (AR). FY 2022
2025-01-09 Korean
[기재정정]감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) system, specifically a 'Correction Report' (정정신고) regarding a previously submitted 'Audit Report' (감사보고서 제출). It details changes to financial data and audit opinions (from 'disclaimer of opinion' to 'unqualified opinion'). Since this is a formal regulatory disclosure of audit results and financial corrections rather than the full annual report itself, it falls under the Audit Report / Information category. FY 2023
2025-01-09 Korean
기타시장안내
Legal Proceedings Report Classification · 100% confidence The document is an official notice from the Korea Exchange (KRX) regarding the decision to maintain the listing of Inbiogen following a review of their improvement plan and audit results. It is a regulatory announcement concerning market status and trading resumption, which does not fit into specific categories like M&A, dividends, or financial reports. Therefore, it is classified as a Regulatory Filing (RNS).
2025-01-09 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.